1. Home
  2. GSRF vs KRMD Comparison

GSRF vs KRMD Comparison

Compare GSRF & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSRF

GSR IV Acquisition Corp. Class A ordinary share

N/A

Current Price

$10.03

Market Cap

294.6M

Sector

N/A

ML Signal

N/A

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

HOLD

Current Price

$4.52

Market Cap

221.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSRF
KRMD
Founded
2023
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
294.6M
221.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
GSRF
KRMD
Price
$10.03
$4.52
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.00
AVG Volume (30 Days)
122.2K
158.2K
Earning Date
01-01-0001
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
56.67
EPS
N/A
0.05
Revenue
N/A
$33,646,463.00
Revenue This Year
N/A
$24.39
Revenue Next Year
N/A
$18.14
P/E Ratio
$184.52
$90.80
Revenue Growth
N/A
17.98
52 Week Low
$9.96
$1.87
52 Week High
$10.09
$6.61

Technical Indicators

Market Signals
Indicator
GSRF
KRMD
Relative Strength Index (RSI) 54.43 37.64
Support Level $9.96 $3.80
Resistance Level $10.05 $5.12
Average True Range (ATR) 0.01 0.24
MACD -0.00 0.00
Stochastic Oscillator 26.00 22.37

Price Performance

Historical Comparison
GSRF
KRMD

About GSRF GSR IV Acquisition Corp. Class A ordinary share

GSR IV Acquisition Corp is a blank check company.

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Share on Social Networks: